Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID‐19

OBJECTIVES: Coronavirus disease 2019 (COVID‐19) is rapidly spreading worldwide. Lianhua Qingwen capsule (LQC) has shown therapeutic effects in patients with COVID‐19. This study is aimed to discover its molecular mechanism and provide potential drug targets. MATERIALS AND METHODS: An LQC target and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cell Prolif
Main Authors: Xia, Qi‐Dong, Xun, Yang, Lu, Jun‐Lin, Lu, Yu‐Chao, Yang, Yuan‐Yuan, Zhou, Peng, Hu, Jia, Li, Cong, Wang, Shao‐Gang
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2020
Assuntos:
Original Manuscripts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7705900/
https://ncbi.nlm.nih.gov/pubmed/33140889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12949
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares